Aoki v. FMT Corp.

District Court, D. New Hampshire·Decided April 22, 1999·No. CV-96-42-JD·Published

Opinion

Aoki v. FMT Corp. CV-96-42-JD 04/22/99 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Aoki Technical Laboratory, Inc.

v. Civil No. 96-42-JD

FMT Corporation, Inc.

O R D E R

The defendant, FMT Corporation, moves for partial summary

judgment (document no. 233) asserting the preclusive effect of

prior litigation involving the same patents that are at issue in

this case. Aoki Technical Laboratory argues that FMT's motion

should be stricken as untimely and also objects to summary

judgment, contending that the prior case has no preclusive effect

as to Aoki's claims in this case. FMT moves for leave to file a

reply to Aoki's objection, and Aoki opposes FMT's reply.

Standard of Review

Summary judgment is appropriate when "the pleadings,

depositions, answers to interrogatories, and admissions on file,

together with the affidavits, if any, show that there is no

genuine issue as to any material fact and that the moving party

is entitled to a judgment as a matter of law." Fed. R. Civ. P.

56(c). The record presented for summary judgment is considered

in the light most favorable to the nonmoving party. Glaxo Group Ltd. v. TorPharm, Inc., 153 F.3d 1366, 1370 (Fed. Cir. 1998).

"When a party moves for summary judgment of res judicata or other

basis of preclusion, it must be shown that the claim or issue

would be precluded even on the non-movant's version of the

facts." Amgen, Inc. v. Genetics Inst., 98 F.3d 1328, 1330 (Fed.

Cir. 1996). The moving party must initially demonstrate "the

absence of a genuine material guestion of disputed fact and

establish[] that [it] is entitled to judgment as a matter of

law." Arkie Lures, Inc. v. Gene Larew Tackle, Inc., 119 F.3d

953, 955 (Fed. Cir. 1997) .

Discussion

Aoki seeks a declaratory judgment that three patents held by

FMT are invalid under the "public use" and "on sale" bars of 35

U.S.C.A. § 102(b), are unenforceable, and are not infringed by

Aoki. FMT moves for partial summary judgment contending that

Aoki is precluded from litigating the issue of invalidity

pursuant to section 102(b) based on the judgment in FMT Corp. v.

Constar Plastics, Inc., N o .1:91-CV-3148-GET (N.D. G a . filed Dec.

1991) .1 Aoki responds that the motion should be disallowed

■ ‘ ■Although FMT discusses the FMT Corp. v. Nissei ASB Co., No. 90-CV-7 86-GET (N.D. G a .) case in detail, FMT does not argue that the Nissei case has any preclusive effect in this litigation.

2 because FMT did not raise collateral estoppel in its objection to

Aoki's motion for summary judgment based on section 102(b). Aoki

also objects to collateral estoppel on grounds that the issue was

not fully litigated previously, that Aoki was not in privity with

Constar, and that the Constar case ended in a consent judgment.

A. Timeliness of FMT's Motion

Aoki moved for summary judgment in its favor on the issue of

patent invalidity pursuant to section 102(b). FMT sought

additional time to conduct discovery before filing an objection,

including discovery pertaining to the application of collateral

estoppel. However, FMT did not assert collateral estoppel in its

objection to Aoki's motion for summary judgment.

Without making a separate motion to strike FMT's motion for

partial summary judgment, Aoki argues that FMT's motion for

partial summary judgment based on collateral estoppel should be

stricken as a late objection to Aoki's motion for summary

judgment. Aoki cites cases in which objections to motions for

summary judgment were stricken when they were filed after the

applicable deadline. Aoki provides no authority for its novel

theory that a motion for summary judgment must be viewed as a

late objection to a prior motion for summary judgment on the same

issue. Accordingly, on the record presented, FMT's motion for

3 partial summary judgment is not stricken as a late objection to

Aoki's previous motion for summary judgment.

B. Collateral Estoppel

In support of its motion for partial summary judgment, FMT

asserts that the same section 102 (b) defenses raised by Aoki in

this case were raised by Aoki's customer, Constar Plastics, in

previous litigation with FMT about the same patents.2 FMT states

that "Constar, after trial, acknowledged that the § 102(b)

defense was not established and the Special Master recommended

dismissal of this defense." FMT contends that Aoki and Constar

agreed to cooperate on the section 102 (b) defense based on

Constar's promise not to settle and to pursue the issue to its

conclusion. FMT says, "Aoki is bound under the doctrine of

collateral estoppel by the decision in FMT v. Constar finding

FMT's patents not invalid, including over the § 102(b) public use

and on sale defense." In response, Aoki contends that the

2Constar also raised other defenses, not at issue here, asserting patent invalidity based on indefiniteness, 35 U.S.C.A. § 112, and obviousness, 35 U.S.C.A. § 103. FMT seems to support its collateral estoppel argument in part by reference to the special master's finding in the Constar case that the evidence in support of Constar's obviousness defense under section 103 was insufficient and that the court adopted the special master's report. Section 103 has not been shown to be relevant to the section 102(b) claims at issue in this case.

4 Constar case can have no preclusive effect as to its claims here,

on grounds that there was not a trial on the merits in the

Constar case, that Aoki's participation was limited, and that the

case ended in a consent judgment.3

When considering the doctrine of res judicata in a patent

case, the district court applies the law of its own circuit.4

See Epic Metals Corp. v. H.H. Robertson Co., 870 F.2d 1574, 1576

(Fed. Cir. 1989). "A judgment that is entered with prejudice

under the terms of a settlement, whether by stipulated dismissal,

a consent judgment, or a confession of judgment, is not subject

to collateral attack by a party or a person in privity, and it

bars a second suit on the same claim or cause of action."

Lanqton v. Hogan, 71 F.3d 930, 935 (1st Cir. 1995). See also

Foster v. Hallco Mfg. Co., 947 F.2d 469, 480-83 (Fed. Cir. 1991)

(discussing preclusive effect of consent decree pertaining to

patent validity).

The doctrine of collateral estoppel "bars relitigation of

any issue that, 1) a party had a 'full and fair opportunity to

3The court has considered FMT's reply and Aoki's objection to FMT's motion for leave to reply.

4The broader doctrine of res judicata includes both claim and issue preclusion although each has its own distinct reguirements. See Monarch Life Ins. Co. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Aoki v. FMT Corp., (D.N.H. 1999).

Aoki v. FMT Corp. (Aoki v. FMT Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Richards v. Jefferson County
517 U.S. 793 (Supreme Court, 1996)
Gonzalez Abreau v. Banco Central
27 F.3d 751 (First Circuit, 1994)
Monarch Life Insurance v. Ropes & Gray
65 F.3d 973 (First Circuit, 1995)
Epic Metals Corporation v. H.H. Robertson Company
870 F.2d 1574 (Federal Circuit, 1989)
Victor Decosta v. Viacom International, Inc.
981 F.2d 602 (First Circuit, 1992)
In Re Jerre M. Freeman
30 F.3d 1459 (Federal Circuit, 1994)
Boston Scientific Corp. v. Schneider (Europe) AG
983 F. Supp. 245 (D. Massachusetts, 1997)